Single-dose study of M707102 in healthy subjects

Phase 1, single dose study of M707102 in healthy subjects

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2071230090

Enrollment

Registered

2023-11-19

Start date

2024-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic keratosis

Interventions

M707102 or M707102 vehicle will be applied topically under occlusion

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male subjects from 18 to 49 years of age (at the time of informed consent)

Exclusion criteria

Exclusion criteria: (1) Individuals with a history or complications of any of the following diseases 1)Actinic keratosis, porphyria 2)Photosensitivity, metabolic diseases such as aminoaciduria, idiopathic or immune diseases such as polymorphic light eruption, genetic diseases such as xeroderma pigmentosum, and diseases for which onset or exacerbation occur due to exposure to sunlight such as systemic lupus erythematosus and pemphigus (2) Individuals with a history of allergy or hypersensitivity (including skin hypersensitivity) to any ingredient or metabolite of the investigational medicinal product (3) Individuals who are judged to be unsuitable as subject by the principal (sub) investigator

Design outcomes

Primary

Measure	Time frame
Safety, Pharmacokinetics	—

Contacts

Public ContactClinical Trials Information -

Maruho Co.,Ltd. Kyoto R&D Center

ctinfo@mii.maruho.co.jp+81-75-325-3279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026